BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  e-Therapeutics plc - Interim Results for the Six Months Ended 31 July 2012

  October 22, 2012

   · 

  1 min read
• Lone Star Bio

  Precision Spine Plans to Introduce Three New Products at North American Spine Society Meeting in Dallas

  October 22, 2012

   · 

  1 min read
• Drug Development

  Synergy Pharmaceuticals Initiates Dosing of Healthy Volunteers in Phase I Trial of SP-333, a Second-Generation GC-C Agonist to Treat Ulcerative Colitis

  October 22, 2012

   · 

  1 min read
• Biotech Bay

  First DataBank Inc. Releases Enhanced Drug Knowledge to Support Interoperable Medication Management

  October 22, 2012

   · 

  1 min read
• Biotech Beach

  Trius Therapeutics Release: Tedizolid Safety Data Presented at IDWeek

  October 22, 2012

   · 

  1 min read
• Pharm Country

  ZIOPHARM Oncology, Inc. Issues Statement Regarding Misleading Blog

  October 22, 2012

   · 

  1 min read
• Business

  Jim Daly to Join Incyte Corporation as Executive Vice President and Chief Commercial Officer

  October 22, 2012

   · 

  1 min read
• Business

  Infinity Pharmaceuticals Inc. Announces the Date of Its Third Quarter 2012 Financial Results Conference Call and Webcast

  October 22, 2012

   · 

  1 min read
• Drug Development

  Derma Sciences, Inc. on Track to Begin Phase 3 Program With DSC127 in December Following Meeting With FDA

  October 22, 2012

   · 

  1 min read
• Policy

  Orexigen Therapeutics, Inc. Receives Dispute Response Indicating FDA is Highly Supportive of Exploration of a Faster Path to Resubmission of the Contrave NDA

  October 22, 2012

   · 

  7 min read